NL173400C - Werkwijze ter bereiding van farmaceutische preparaten op basis van 2-gesubstitueerde-5-sulfamylbenzoezuren, alsmede werkwijze ter bereiding van 2-gesubstitueerde-5-sulfamylbenzoezuren. - Google Patents

Werkwijze ter bereiding van farmaceutische preparaten op basis van 2-gesubstitueerde-5-sulfamylbenzoezuren, alsmede werkwijze ter bereiding van 2-gesubstitueerde-5-sulfamylbenzoezuren.

Info

Publication number
NL173400C
NL173400C NLAANVRAGE7112598,A NL7112598A NL173400C NL 173400 C NL173400 C NL 173400C NL 7112598 A NL7112598 A NL 7112598A NL 173400 C NL173400 C NL 173400C
Authority
NL
Netherlands
Prior art keywords
sulfamylbenoic
acids
substituted
preparation
production
Prior art date
Application number
NLAANVRAGE7112598,A
Other languages
English (en)
Other versions
NL173400B (nl
NL7112598A (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7112598A publication Critical patent/NL7112598A/xx
Publication of NL173400B publication Critical patent/NL173400B/nl
Application granted granted Critical
Publication of NL173400C publication Critical patent/NL173400C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NLAANVRAGE7112598,A 1970-09-14 1971-09-14 Werkwijze ter bereiding van farmaceutische preparaten op basis van 2-gesubstitueerde-5-sulfamylbenzoezuren, alsmede werkwijze ter bereiding van 2-gesubstitueerde-5-sulfamylbenzoezuren. NL173400C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7215670A 1970-09-14 1970-09-14

Publications (3)

Publication Number Publication Date
NL7112598A NL7112598A (nl) 1972-03-16
NL173400B NL173400B (nl) 1983-08-16
NL173400C true NL173400C (nl) 1984-01-16

Family

ID=22105942

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7112598,A NL173400C (nl) 1970-09-14 1971-09-14 Werkwijze ter bereiding van farmaceutische preparaten op basis van 2-gesubstitueerde-5-sulfamylbenzoezuren, alsmede werkwijze ter bereiding van 2-gesubstitueerde-5-sulfamylbenzoezuren.

Country Status (14)

Country Link
JP (1) JPS5512422B1 (nl)
AT (1) AT323187B (nl)
AU (1) AU468590B2 (nl)
BE (1) BE772381A (nl)
CA (1) CA983489A (nl)
CH (2) CH552575A (nl)
ES (2) ES394830A1 (nl)
FR (1) FR2106514B1 (nl)
GB (1) GB1353357A (nl)
KE (1) KE2573A (nl)
MY (1) MY7500253A (nl)
NL (1) NL173400C (nl)
SE (1) SE401673B (nl)
ZA (1) ZA715851B (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929803A (en) * 1974-05-28 1975-12-30 Pfizer Aryl carboxylic acids
EP0068408A1 (en) * 1980-11-10 1983-01-05 Mochida Pharmaceutical Co., Ltd. Antiviral compositions and a method for treating virus diseases
JPS58192863A (ja) * 1982-05-06 1983-11-10 Hodogaya Chem Co Ltd 新規アミノスルホニル安息香酸エステル誘導体
AU539797B2 (en) * 1981-06-22 1984-10-18 Hodogaya Chemical Co. Ltd. Aminosulfonyl benzoic acid derivatives
NL8220205A (nl) * 1981-06-22 1983-05-02 Mochida Pharm Co Ltd Farmaceutisch preparaat met anti-virusactiviteit.
JPS6323210U (nl) * 1986-07-31 1988-02-16
DE3732374A1 (de) * 1987-09-25 1989-04-06 Basf Lacke & Farben Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel
JPH0248510U (nl) * 1988-09-28 1990-04-04
DE19941559A1 (de) * 1999-09-01 2001-03-15 Aventis Pharma Gmbh Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie
EE200200095A (et) * 1999-09-01 2003-04-15 Aventis Pharma Deutschland Gmbh Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH433378A (de) * 1962-03-09 1967-04-15 Ciba Geigy Verfahren zur Herstellung neuer Anthranilsäurederivate
FR1525352A (fr) * 1967-04-06 1968-05-17 Ile De France Procédé de préparation des acides 2-alcoxy-5-sulfamido-benzoïques

Also Published As

Publication number Publication date
DE2145686A1 (de) 1972-04-20
AT323187B (de) 1975-06-25
ES421977A1 (es) 1976-05-01
CH552575A (fr) 1974-08-15
JPS5512422B1 (nl) 1980-04-02
CA983489A (en) 1976-02-10
KE2573A (en) 1975-10-31
SE401673B (sv) 1978-05-22
NL173400B (nl) 1983-08-16
CH569706A5 (nl) 1975-11-28
DE2145686B2 (de) 1977-07-07
GB1353357A (en) 1974-05-15
MY7500253A (en) 1975-12-31
NL7112598A (nl) 1972-03-16
AU3308471A (en) 1973-03-08
AU468590B2 (en) 1976-01-15
ES394830A1 (es) 1974-12-01
FR2106514A1 (nl) 1972-05-05
ZA715851B (en) 1972-05-31
BE772381A (fr) 1972-03-09
FR2106514B1 (nl) 1975-08-01

Similar Documents

Publication Publication Date Title
NL170143C (nl) Werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat met anti-ontstekingsactiviteit, alsmede werkwijze ter bereiding van daarvoor geschikte polyarylimidazolen.
NL174943C (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van een 8-azapurin-6-onderivaat.
NL169994C (nl) Werkwijze voor de bereiding van tereftaalzuur.
NL150680B (nl) Werkwijze ter bereiding van farmaceutische preparaten.
NL170140C (nl) Werkwijze ter bereiding van farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van 1,4-dihydropyridine 3,5-dicarbonzuuresters.
NL174547B (nl) Werkwijze ter bereiding van benzoylpropionzuurderivaten, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL7601455A (nl) Werkwijze ter bereiding van prostaglandine-analo- ga; werkwijze ter bereiding van farmaceutische preparaten, alsmede gevormde voortbrengselen.
NL7501032A (nl) Werkwijze ter bereiding van anti-tuberkelmid- delen, alsmede farmaceutische preparaten die deze middelen bevatten.
NL179729C (nl) Werkwijze ter bereiding van farmaceutische preparaten op basis van 1h-indazool-3-carbonzuurderivaten alsmede werkwijze ter bereiding van deze 1h-indazool-3-carbonzuurderivaten.
NL173400C (nl) Werkwijze ter bereiding van farmaceutische preparaten op basis van 2-gesubstitueerde-5-sulfamylbenzoezuren, alsmede werkwijze ter bereiding van 2-gesubstitueerde-5-sulfamylbenzoezuren.
NL179583C (nl) Werkwijze ter bereiding van een geneesmiddel met anti-inflammatoire werking, en werkwijze ter bereiding van geneeskrachtige aroyl-gesubstitueerde fenylazijnzuurderivaten.
NL168210B (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van cyclische carbon- zuurderivaten.
NL170284C (nl) Werkwijze ter bereiding van 1.2.3.5.6.12.13.13a-octahydro 12 oxoindolo Ÿ3.2.1-d.eŸpyrido Ÿ3.2.1-i.jŸnaftyridinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL173167C (nl) Werkwijze ter bereiding van farmaceutische preparaten, op basis van n-acyltryptofaanderivaten, alsmede werkwijze ter bereiding van n-acyltryptofaanderivaten.
NL174830C (nl) Werkwijze ter bereiding van een purinenucleoside van beta-d-arabinofuranose en werkwijze ter bereiding van farmaceutische preparaten op basis van deze verbinding.
NL172657C (nl) Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare pyrazoloÿ3.4-bÿ-pyridine-derivaten.
NL7508706A (nl) Werkwijze ter bereiding van pyrazofurinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL166470C (nl) Werkwijze ter bereiding van een geneesmiddel met bronchi-verwijdende en de afscheiding van maagzuur tegengaande werking, alsmede werkwijze ter bereiding van daarin toegepaste pyrimidinonverbindingen.
NL175063C (nl) Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL149082B (nl) Werkwijze ter bereiding van farmaceutische preparaten, gevormde preparaten en werkwijze ter bereiding van daarvoor geschikte thiazolino (3,2-a)-5-pyrimidinonderivaten.
NL176266C (nl) Werkwijze ter bereiding van cefalosporineesters en farmaceutische preparaten daaruit.
NL176366C (nl) Werkwijze ter bereiding van 4,9,11-trieensteroidverbindingen, werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.
NL7409481A (nl) Werkwijze ter bereiding van pyrazolidinederi- vaten, werkwijze ter bereiding van farmaceuti- sche preparaten en gevormde preparaten.
NL7502951A (nl) Werkwijze ter bereiding van benzopyrano-benzo- pyranen en benzothiopyrano-benzothiopyranen, werkwijze ter bereiding van farmaceutische preparaten en gevormde preparaten.
NL179205C (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte aminoalkylesters van xantheen-9-carbonzuur.

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee